Table 2. Incidence of the most common adverse events up to 1 year after transplant.
Adverse events | Incidence of adverse events (%) | p-Value | |
---|---|---|---|
Everolimus | CNI | ||
anemia | 13.92 | 8.52 | 0.004 |
hyperlipidemia | 10.15 | 5.23 | 0.006 |
hypercholesterolaemia | 11.11 | 5.59 | 0.01 |
hypokalaemia | 6.25 | 1.63 | 0.02 |
proteinuria | 8.55 | 3.53 | 0.007 |
stomatitis | 18.04 | 1.94 | <0.00001 |
mouth ulceration | 15.38 | 0.75 | <0.00001 |
acne | 10.25 | 1.63 | 0.0005 |
thrombocytopenia | 5.12 | 2.23 | 0.29 |
cytomegalovirus | 8.90 | 11.59 | 0.11 |
BK virus | 2.85 | 4.88 | 0.14 |
urinary tract infection | 21.48 | 25.61 | 0.27 |
diabetes mellitus | 4.92 | 8.29 | 0.16 |
hypertriglyceridaemia | 2.16 | 2.51 | 0.77 |
malignancy | 5.62 | 7.08 | 0.51 |
cough | 6.97 | 7.35 | 0.90 |